CDHA CAAR

December 17, 2019

CAAR – US National Institutes of Health Funding Opportunities – December 17, 2019

Filed under: Employment/Funding Opportunities — Tags: — admin @ 5:30 pm

A. “Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 – Clinical Trial Optional),” (PAR-20-070, a reissue of PAR-18-645, National Institute on Aging, application deadlines Feb. 16, June 16, and Oct. 16). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional),” (PAR-20-071).

grants.nih.gov/grants/guide/pa-files/PAR-20-070.html

B. “Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed),” (PAR-20-076, a reissue of PAR-17-096, National Institute on Aging, in conjunction with other agencies, application deadlines May 26, 2020; May 25, 2021; May 25, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-20-076.html

C. “Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed),” (RFA-OD-20-005, a reissue of RFA-OD-19-016, National Institute on Aging, in conjunction with other agencies, application deadlines February 14, 2020, November 3, 2020, November 3, 2021). Note: There are four companion funding announcements (follow the link under “Companion Funding Opportunity”): “Small Research Grants for Analyses of Down Syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed),” (RFA-OD-20-006); “Development of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project Data Coordinating Center (U2C Clinical Trial Not Allowed),” (RFA-OD-20-007); “INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed),” (RFA-OD-20-004); and, “Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required),” (RFA-OD-20-003).

grants.nih.gov/grants/guide/pa-files/PAR-20-076.html

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress